STX209 (Arbaclofen) for Autism Spectrum Disorders: An 8-Week Open-Label Study

Published in: Journal of Autism and Developmental Disorders

Volume 44, Issue 4, pp. 958-964

DOI: 10.1007/s10803-013-1963-z